Citadel Advisors’s Quipt Home Medical QIPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-73,672
| Closed | -$260K | – | 13994 |
|
|
2025
Q4 | $260K | Sell |
73,672
-183,008
| -71% | -$484K | ﹤0.01% | 10445 |
|
|
2025
Q3 | $670K | Buy |
256,680
+115,151
| +81% | +$266K | ﹤0.01% | 8436 |
|
|
2025
Q2 | $253K | Sell |
141,529
-96,927
| -41% | -$191K | ﹤0.01% | 10184 |
|
|
2025
Q1 | $556K | Buy |
238,456
+106,486
| +81% | +$292K | ﹤0.01% | 8255 |
|
|
2024
Q4 | $403K | Sell |
131,970
-33,845
| -20% | -$91.1K | ﹤0.01% | 9034 |
|
|
2024
Q3 | $484K | Sell |
165,815
-1,438
| -0.9% | -$4.44K | ﹤0.01% | 8329 |
|
|
2024
Q2 | $539K | Buy |
167,253
+23,326
| +16% | +$83.7K | ﹤0.01% | 7899 |
|
|
2024
Q1 | $629K | Buy |
143,927
+118,867
| +474% | +$537K | ﹤0.01% | 7885 |
|
|
2023
Q4 | $128K | Sell |
25,060
-79,527
| -76% | -$381K | ﹤0.01% | 10624 |
|
|
2023
Q3 | $532K | Sell |
104,587
-69,129
| -40% | -$371K | ﹤0.01% | 7928 |
|
|
2023
Q2 | $928K | Buy |
173,716
+95,007
| +121% | +$561K | ﹤0.01% | 6618 |
|
|
2023
Q1 | $552K | Buy |
78,709
+54,363
| +223% | +$335K | ﹤0.01% | 8107 |
|
|
2022
Q4 | $115K | Sell |
24,346
-1,858
| -7% | -$8.11K | ﹤0.01% | 11030 |
|
|
2022
Q3 | $109K | Buy |
+26,204
| New | +$131K | ﹤0.01% | 11011 |
|
|
2022
Q2 | – | Sell |
-16,089
| Closed | -$74.1K | – | 13869 |
|
|
2022
Q1 | $71K | Sell |
16,089
-1,269
| -7% | -$6.43K | ﹤0.01% | 12568 |
|
|
2021
Q4 | $97K | Buy |
+17,358
| New | +$101K | ﹤0.01% | 12753 |
|
Citadel Advisors's QIPT Position: Q1 2026 in Review
Citadel Advisors sold out of Quipt Home Medical (QIPT) in Q1 2026, closing a stake of 73,672 shares — an estimated $260K sold.
Citadel Advisors first reported a position in QIPT in Q4 2021 and held it in 16 quarters. The position peaked at $928K in Q2 2023. 0 funds tracked by Wall St. Rank hold QIPT as of Q1 2026.
- Citadel Advisors reported no remaining Quipt Home Medical position as of Q1 2026 after selling out during the quarter.
- Citadel Advisors sold 73,672 Quipt Home Medical shares in Q1 2026, an estimated $260K.
- Citadel Advisors first reported a position in Quipt Home Medical in Q4 2021 and held it in 16 quarters.
- Citadel Advisors's Quipt Home Medical position peaked at $928K in Q2 2023.
- 0 funds tracked by Wall St. Rank held Quipt Home Medical as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.